Fatty acid synthase hyperactivation in human colorectal cancer: Relationship with tumor side and sex

Oncology

Volumn 71, Issue 5-6, 2007, Pages 327-332

  Notarnicola, Maria ^a   Altomare, Donato Francesco ^b   Calvani, Menotti ^c   Orlando, Antonella ^a   Bifulco, Maurizio ^d   D'Attoma, Benedetta ^a   Caruso, Maria Gabriella ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c Sigma Tau SpA   (Italy)

^d UNIVERSITY OF SALERNO   (Italy)

Author keywords

Colon cancer; Fatty acid synthase; p53 mutation

Indexed keywords

ACETYL COENZYME A; FATTY ACID SYNTHASE; MALONYL COENZYME A; MESSENGER RNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CANCER; ENZYME ACTIVATION; FEMALE; GENDER; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TREATMENT RESPONSE;

AGED; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; ENZYME ACTIVATION; FATTY ACID SYNTHETASE COMPLEX; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; MALE; MUTATION; NEOPLASM STAGING; RNA, MESSENGER; SEX FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 35348839231     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107106     Document Type: Article

References (33)

1. Rashid A, Pizer ES, Moga M, Milgraum LZ, Zahurak M, Pasternack GR, Kuhajda FP, Hamilton SR: Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol 1997;150:201-208.
2. Kuhajda FP: Fatty acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 2000;16:202-208.
3. Kim EK, Miller I, Landree LE, Borisy-Rudin FF, Brown P, Tihan T, Townsend CA, Witters LA, Moran TH, Kuhajda FP, Ronnet GV: Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. Am J Physiol Endocrinol Metab 2002;283:E867-E879.
4. Pizer ES, Kurman RJ, Pasternack GR, Kuhajda FP: Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometrium. Int J Gynecol Pathol 1997;16:45-51.
5. Wilentz R, Witters LA, Pizer E: Lipogenic enzyme fatty acid synthase and acethyl-coenzyme A carboxylase are coexpressed with sterol regulatory element binding protein and Ki-67 in fetal tissue. Pediatr Dev Pathol 2000;3:525-531.
6. Jackowski S, Wang J, Baburina I: Activity of the phosphatidylcholine biosynthetic pathway modulates the distribution of fatty acids into glycerolipids in proliferating cells. Biochim Biophys Acta 2000;1483:301-315.
7. Chalbos D, Chambon M, Ailhaud G, Rochefort H: Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. J Biol Chem 1987;262:9923-9926.
8. Swinnen JV, Heemers H, Deboel L, Foufelle F, Heyns W, Verhoeven G: Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene 2000;19:5173-5181.
9. Kuhajda FP, Piantadosi S, Pasternack GR: Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease. N Engl J Med 1989;321:636-641.
10. Alo PL, Visca P, Marci A, Mangoni A, Botti C, Di Tondo U: Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 1996;77:474-482.
11. Lu S, Zhang X, Badawi AF, El-Sohemy A, Archer MC: Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids. Cancer Lett 2002;184:7-12.
12. Lu S, Archer MC: Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer. Carcinogenesis 2005;26:153-157.
13. Visca P, Alo PL, Del Nonno F, Botti C, Trombetta G, Marandino F, Filippi S, Di Tondo U, Perrone Donnorso R: Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Clin Cancer Res 1999;5:4111-4118.
14. Chalbos D, Joyeux C, Escot C, Galtier F, Rochefort H: Progestin-induced fatty acid synthetase in breast cancer: from molecular biology to clinical applications. Ann NY Acad Sci 1990;595:67-73.
15. Chalbos D, Joyeux C, Galtier F, Rochefort H: Progestin-induced fatty acid synthesase in human mammary tumors: from molecular to clinical studies. J Steroid Biochem Mol Biol 1992;43:223-228.
16. Kusunoki J, Kanatani A, Moller DE: Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome. Endocrine 2006;29:91-100.
17. Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ: Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol 2004;99:1801-1806.
18. Desreumaux P, Ernst O, Geboes K, Gambiez L, Berrebi D, Muller-Alouf H, Hafraoui S, Emilie D, Ectors N, Peuchmaur M, Cortot A, Capron M, Auwerx J, Colombel JF: Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999;117:73-81.
19. Jhon BJ, Irukulla S, Abulafi AM, Kumar D, Mendalls MA: Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther 2006;23:1511-1523.
20. Caruso MG, Notarnicola M, Santillo M, Cavallini A, Di Leo A: Enhanced 3-HMGCoA reductase activity in human colorectal cancer not expressing low density lipoprotein receptor. Anticancer Res 1999;19:451-454.
21. Caruso MG, Notarnicola M, Cavallini A, Di Leo A: 3-hydroxy-3- methylglutaryl coenzyme A reductase activity and low-density lipoprotein receptor expression in diffusetype and intestinal-type human gastric cancer. J Gastroenterol 2002;37:1-5.
22. Notarnicola M, Messa C, Cavallini A, Bifulco M, Tecce MF, Eletto D, Di Leo A, Montemurro S, Laezza C, Caruso MG: Higher farnesyl diphosphate synthase activity in human colorectal cancer: inhibition of cellular apoptosis. Oncology 2004;67:351-358.
23. Caruso MG, Notarnicola M, Bifulco M, Laezza C, Guerra V, Altomare DF, Memeo V, Lorusso D, Demma I, Di Leo A: Increased farnesyltransferase activity in human colorectal cancer: relationship with clinico-pathological features and K-ras mutation. Scand J Gastroenterol 2003;38:80-85.
24. Notarnicola M, Linsalata M, Caruso MG, Caruso ML, Altomare DF, Lorusso D, Leo S, Di Leo A: Genetic and biochemical changes in colorectal carcinoma in relation to morphologic characteristics. Oncol Rep 2003;10:1987-1991.
25. Li JN, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, Han WF, Pizer ES: Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res 2001;61:1493-1499.
26. Notarnicola M, Cavallini A, Cardone R, Pezzolla F, Demma I, Di Leo A: K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer. Dig Liver Dis 2000;32:131-136.
27. Notarnicola M, Messa C, Pricci M, Guerra V, Altomare DF, Montemurro S, Caruso MG: Up-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in left-sided human colon cancer. Anticancer Res 2004;24:3837-3842.
28. Messa C, Russo F, Caruso MG, Di Leo A: EGF, TGF-α and EGF-R in human colorectal adenocarcinoma. Acta Oncol 1998;37:285-289.
29. Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RAEM, Moriya Y, van de Velde CJH, van Krieken JHJM : Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 2001;195:171-178.
30. Iacopetta B: Are there two sides to colorectal cancer? Int J Cancer 2002;101:403-408.
31. Gervaz P, Bouzourene H, Cerottini JP, Chaubert P, Benhattar J, Secic M, Wexner S, Givel JC, Belin B: Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon Rectum 2001;44:364-373.
32. Swinnen JV, Vanderhoydonc F, Elgamal AA, Eelen M, Vercaeren I, Heyns W, Verhoeven G: Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int J Cancer 2000;88:176-179.
33. Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T, Bubley G, Balk S, Loda M: Fatty acid expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res 2003;1:707-715.